THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INADEQUATE RESPONSE TO CHEMOTHERAPY. THE PRELIMINARY EXPERIENCE FROM THE RAFTING TRIAL von Filonenko, K., Domingo‐Domenech, E., Gotti, M., Núñez, J., Rambaldi, A., Rodríguez, A., Tarella, C., Bednarek, M., Gallamini, A., Zaucha, J. M.

Volltext

Precision medicine approach to genetic cardiomyopathy von Filonenko, K., Katus, H. A., Meder, B.

Volltext

Baseline‐PET derived metrics are the most relevant factors for risk stratification in early‐stage nonbulky HL: preliminary results of the RAFTING trial von Zaucha, J. M., Picardi, M., Kurlapski, M., Patti, C., Domingo‐Domenech, E., Sanz, R. Garcia, Rossi, A., Lopez‐jimenez, J., Trentin, L., Gotti, M., Viviani, S., Sorasio, R., Giza, A., Martinez‐Munoz, C., Nunez‐Cespedes, J., Filonenko, K., Chauvie, S., Guerra, L., Rambaldi, A., Sureda, A., Gallamini, A.

Volltext

SUBTYPES OF MALIGNANT LYMPHOMAS IN UKRAINE, ACCORDING TO 2016 WHO CLASSIFICATION. PRELIMINARY REPORT OF THE UKRAINIAN LYMPHOMA REGISTRY von Skrypets, T., Stepanishyna, Y., Galli, G. R., Manni, M., Hubareva, A., Tytorenko, I., Martynchyk, A., Aleksik, O., Shudrak, N., Pastushenko, Y., Novosad, O., Filonenko, K., Kadnikova, T., Kushchevyi, Y., Federico, M., Kriachok, I.

Volltext

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA FROM HIGH‐RISK GROUP von Filonenko, K., Kriachok, I., Martynchyk, A., Titorenko, I., Stepanishyna, Y., Aleksyk, O., Ukianchenko, K., Pastushenko, I., Kushchevyy, Y., Novosad, O., Karnabeda, O., Diagil, I., Kozlov, V.

Volltext

PB2283: COVID‐19 (SARS‐COV‐2 INFECTION) IN LYMPHOMA PATIENTS von Tytorenko, I., Kryachоk, I., Alexik, O., Kadnikova, T., Martynchik, A., Novosad, O., Pastyshenko, Y., Stepanishina, Y., Shokun, N., Filonenko, K.

Volltext

OR57 Coincidence of multiple myeloma and non-Hodgkin's lymphoma in female von Filonenko, K, Kriachok, I, Galkin, F, Grabovoy, A

Volltext

781 GSTP1 Polymorphism Can Predict Clinical Outcome in Hodgkin's Lymphoma Patients von Svergun, N, Kriachok, I, Khranovska, N, Novosad, O, Tytorenko, I, Martynchyk, A, Filonenko, K

Volltext

Bio-inspired design and movement generation of dung beetle-like legs von Ignasov, J., Kapilavai, A., Filonenko, K., Larsen, J. C., Baird, E., Hallam, J., Büsse, S., Kovalev, A., Gorb, S. N., Duggen, L., Manoonpong, P.

Volltext

9231 POSTER BEACOPP-14 Vs. BEACOPP-esc in Patients With Hodgkin's Disease From Poor-prognosis Group – Updated Results of Prospective Randomized Multicenter Study von Titorenko, I, Kriachok, I, Filonenko, K, Novosad, O, Alexik, O, Kadnikova, T, Martynchik, A, Kuscshevyy, E, Pastushenko, Y

Volltext

1523PCLINICAL AND LABORATORY PROGNOSTIC FACTORS OF TOXICITY OF BREAST CANCER CHEMOTHERAPY von Filonenko, K., Hubareva, H., Kriachok, I., Aleksyk, O., Svergun, N.

Volltext

Clinical and Laboratory Prognostic Factors of Toxicity of Breast Cancer Chemotherapy von Filonenko, K., Hubareva, H., Kriachok, I., Aleksyk, O., Svergun, N.

Volltext

Comparison of the efficiency of peripheral blood stem cell apheresis on the blood cell separators von Filonenko, Kateryna, Zarutska, Veronika, Martynchyk, Arina, Kushchevyi, Yevhan, Stepanishyna, Yana, Kriachok, Irina

Volltext

The role of radiation therapy in DLBCL treatment in a single institution study von Kryachok, I., Aleksyk, O., Filonenko, K., Fedorenko, Z., Tytorenko, I., Martynchyk, A.V., Stepanishyna, I., Koutsenko, L.

Volltext

PF477 CHANGES IN OVERALL SURVIVAL OF HODGKIN'S LYMPHOMA PATIENTS IN UKRAINIAN POPULATION DURING LAST DECADES von Filonenko, K., Kriachok, I., Tytorenko, I., Fedorenko, Z., Koutsenko, L.

Volltext

R-da-EPOCH vs R-CHOP in patients with primary mediastinal large B-cell lymphoma: Results of randomised (prospective) multicenter study von Kryachok, I., Stepanishyna, I., Tytorenko, I., Martynchyk, A.V., Filonenko, K., Novosad, O., Kadnikova, T., Pastushenko, I., Kushchevyy, Y., Skrypets, T., Aleksyk, O., Ulianchenko, K.

Volltext

Cardiac Toxicity Prevention in Patients with Breast Cancer Treated with Fac Chemotherapy von Filonenko, K., Hubareva, H., Askolskyi, A., Aleksyk, O., Svergun, N., Kriachok, I.

Volltext

1524PCARDIAC TOXICITY PREVENTION IN PATIENTS WITH BREAST CANCER TREATED WITH FAC CHEMOTHERAPY von Filonenko, K., Hubareva, H., Askolskyi, A., Aleksyk, O., Svergun, N., Kriachok, I.

Volltext

961PINTERMEDIATE RESULTS OF TREATMENT OF PRIMARY MEDIASTINAL LARGE В-CELL LYMPHOMA WITH DA-EPOCH-R REGIMEN von Stepanishyna, I., Kryachok, I., Titorenko, I., Filonenko, K., Martynchyk, A., Novosad, O., Sokolov, V., Vereschako, R.

Volltext

Intermediate Results of Treatment of Primary Mediastinal Large В-Cell Lymphoma with Da-Epoch-R Regimen von Stepanishyna, I., Kryachok, I., Titorenko, I., Filonenko, K., Martynchyk, A., Novosad, O., Sokolov, V., Vereschako, R.

Volltext